サンプル依頼リスト カート
  • English
  • Korean
表紙：感染症治療薬の世界市場：治療モード別、感染タイプ別、流通チャネル別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2023～2030年）
市場調査レポート
商品コード
1408897

感染症治療薬の世界市場：治療モード別、感染タイプ別、流通チャネル別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2023～2030年）

Infectious Disease Therapeutics Market, By Mode of Treatment, By Infectious Type, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 303 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
感染症治療薬の世界市場：治療モード別、感染タイプ別、流通チャネル別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2023～2030年）
出版日: 2024年01月07日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

世界の感染症治療薬の市場規模は、2022年に680億3,400万米ドルに達し、2023～2030年にかけてCAGR 8.2%で拡大すると予測されています。

感染症治療薬市場 - 市場力学

感染症患者数の増加が市場の成長を牽引すると予測

感染症患者数の増加は、治療介入に対する需要を促進する可能性があります。これは、ライフスタイルの変化、抗生物質耐性、海外旅行、人口密度などの要因によるものと考えられます。感染症の例としては、インフルエンザ、麻疹、HIV、連鎖球菌性咽頭炎、COVID-19、サルモネラなどが挙げられます。感染症は世界的に蔓延しているが、その流行状況は様々です。例えば、米国では毎年5人に1人がインフルエンザ・ウイルスに感染しているのに対し、プリオン病と診断された人の数は300人にも満たないです。国立衛生統計センターによると、感染症や寄生虫症を主病名とする救急外来受診者数は約380万人です。しかし、バイオテクノロジーと製薬研究の絶え間ない進歩は、感染症に対するより効果的で的を絞った治療法の開発の機会を提供しています。さらに、景気後退や不確実性は、ヘルスケア予算や感染症治療薬への資金配分に影響を与える可能性があります。

感染症治療薬市場 - 主な洞察

世界の感染症治療薬市場は、予測期間（2023～2030年）に約8.2%のCAGRで毎年成長すると推定されています。

治療モードのセグメンテーションに基づくと、医薬品が2022年に最大の市場シェアを示すと予測されました。

感染タイプ別では、2022年には細菌性タイプが主要タイプとなりました。

流通チャネル別では、2022年に病院が主要タイプでした。

地域別では、北米が2022年の主要収益源です。

感染症治療薬市場 - セグメンテーション分析：

感染症治療薬の世界市場は、治療モード、感染タイプ、流通チャネル、地域に基づいてセグメント化されます。

市場は、治療モードに基づいて3つのカテゴリーに分けられます（ワクチンと医薬品）。医薬品セグメントが市場を独占しています。数多くの世界の保健機関、政府、NGOが、特に感染症が公衆衛生上大きな障害となっている地域において、感染症治療薬の普及促進に積極的に貢献しています。

市場は感染症のタイプによって2つのカテゴリーに分けられます（ウイルス性、寄生性、真菌性、細菌性、その他）。細菌セグメントが市場を大きく左右しています。細菌感染症は、特に発展途上地域において、公衆衛生上の大きな懸念事項であり続けています。政府、非営利団体、製薬企業の連携による世界ヘルスイニシアチブの取り組みは、効果的な治療法の利用可能性を高め、細菌感染症の世界の負担を軽減することに努めています。

市場は流通チャネルによって2つのカテゴリーに分けられます（クリニック、病院、その他）。市場を独占しているのは病院セグメントです。市場は主に病院セグメントによって支配されています。病院は感染症の特定と治療において重要な役割を果たしています。病院には診断施設、検査室、感染症の原因物質を特定し、適切な治療手段を推奨するために協力する医療専門家チームがあります。

感染症治療薬市場 - 地理的洞察

感染症治療薬市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカなど、さまざまな地域に地理的に広がっています。これらの地域は、事業に関与する国に基づいてさらに分割されます。成長という点では、抗ウイルス薬の普及が進み、米国に多数のメーカーが存在することから、北米が市場を独占すると予想されます。米国はヘルスケアおよび製薬分野における研究開発の拠点として機能しており、研究開発への多額の投資が感染症に対する新たな治療薬の発見につながっています。米国医薬品統計によると、米国の製薬産業が生み出す収益は2021年に5,500億米ドルに達し、米国人は同年中に5,769億米ドルを医薬品に費やしました。米国は2025年までに6,050～6,350億米ドルを医薬品に費やすと予測されています。抗ウイルス薬の市場開拓は、ウイルス感染症の治療に重要な役割を果たし、市場全体の成長に貢献しています。抗ウイルス薬の普及は、ウイルス感染と闘うための研究開発への継続的な取り組みを反映しています。一方、欧州は、主に感染症の予防と診断に対する支出が増加していることから、市場成長において2番目に大きな地域となっています。

感染症治療薬市場 - 競合情勢：

米国の製薬産業は毎年、医療上の大きなメリットをもたらすさまざまな新薬を発表しています。しかし、こうした新薬の中には高価なものも少なくなく、民間企業や連邦政府の医療費増大の一因となっています。市場に参入するために、新興のバイオ医薬品企業（新興企業や中堅企業が多い）は、感染症やニッチな分野に特化した革新的な治療薬を世に送り出しています。一方、感染症治療薬の開発・商業化においては、研究開発力のある大手製薬企業がしのぎを削っています。これらの企業は、大規模な臨床試験を実施し、世界の流通を確保するために必要なリソースを有しています。

目次

第1章 感染症治療薬の市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 感染症治療薬の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 感染症治療薬の産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 感染症治療薬市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 感染症治療薬の市場情勢

  • 感染症治療薬市場シェア分析、2022年
  • 内訳データ：主要メーカー別
    • 既存企業の分析
    • 新興企業の分析

第7章 感染症治療薬市場：治療モード別

  • 概要
    • セグメントシェア分析：治療モード別
    • ワクチン
    • 医薬品

第8章 感染症治療薬市場：感染タイプ別

  • 概要
    • セグメントシェア分析：感染タイプ別
    • ウイルス性
    • 寄生虫
    • 真菌
    • バクテリア
    • その他

第9章 感染症治療薬市場：流通チャネル別

  • 概要
    • セグメントシェア分析：流通チャネル別
    • 診療所
    • 病院
    • その他

第10章 感染症治療薬市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：感染症治療薬産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Pfizer Inc.
    • Novartis AG,
    • Gilead
    • GlaxoSmithKline plc
    • Janssen Pharmaceutical, Inc.
    • F. Hoffmann-La Roche Ltd.
    • BioCryst Pharmaceuticals Inc.
    • Merck &Co., Inc.
    • Boehringer Ingelheim GmbH.
    • その他

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Infectious Disease Therapeutics Market: Mode of treatment Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Mode of treatment
  • TABLE Global Infectious Disease Therapeutics Market, by Mode of treatment 2018-2030 (USD Million)
  • TABLE Infectious Disease Therapeutics Market: Infectious Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Infectious Type
  • TABLE Global Infectious Disease Therapeutics Market, by Infectious Type 2018-2030 (USD Million)
  • TABLE Infectious Disease Therapeutics Market: Distribution channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution channel
  • TABLE Global Infectious Disease Therapeutics Market, by Distribution channel 2018-2030 (USD Million)
  • TABLE Infectious Disease Therapeutics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Infectious Disease Therapeutics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Infectious Disease Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Infectious Disease Therapeutics Market, by Mode of treatment, 2018-2030 (USD Million)
  • TABLE North America Infectious Disease Therapeutics Market, by Infectious Type, 2018-2030 (USD Million)
  • TABLE North America Infectious Disease Therapeutics Market, by Distribution channel, 2018-2030 (USD Million)
  • TABLE Europe Infectious Disease Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Infectious Disease Therapeutics Market, by Mode of treatment, 2018-2030 (USD Million)
  • TABLE Europe Infectious Disease Therapeutics Market, by Infectious Type, 2018-2030 (USD Million)
  • TABLE Europe Infectious Disease Therapeutics Market, by Distribution channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Infectious Disease Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Infectious Disease Therapeutics Market, by Mode of treatment, 2018-2030 (USD Million)
  • TABLE Asia Pacific Infectious Disease Therapeutics Market, by Infectious Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Infectious Disease Therapeutics Market, by Distribution channel, 2018-2030 (USD Million)
  • TABLE Latin America Infectious Disease Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Infectious Disease Therapeutics Market, by Mode of treatment, 2018-2030 (USD Million)
  • TABLE Latin America Infectious Disease Therapeutics Market, by Infectious Type, 2018-2030 (USD Million)
  • TABLE Latin America Infectious Disease Therapeutics Market, by Distribution channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Infectious Disease Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Infectious Disease Therapeutics Market, by Mode of treatment, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Infectious Disease Therapeutics Market, by Infectious Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Infectious Disease Therapeutics Market, by Distribution channel, 2018-2030 (USD Million)

List of Figures

  • FIGURE Infectious Disease Therapeutics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Mode of treatment segment market share analysis, 2022 & 2030
  • FIGURE Mode of treatment segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Infectious Type segment market share analysis, 2022 & 2030
  • FIGURE Infectious Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Distribution channel segment market share analysis, 2022 & 2030
  • FIGURE Distribution channel segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Infectious Disease Therapeutics Market share and leading players, 2022
  • FIGURE Europe Infectious Disease Therapeutics Market share and leading players, 2022
  • FIGURE Asia Pacific Infectious Disease Therapeutics Market share and leading players, 2022
  • FIGURE Latin America Infectious Disease Therapeutics Market share and leading players, 2022
  • FIGURE Middle East and Africa Infectious Disease Therapeutics Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Infectious Disease Therapeutics Market share analysis by country, 2022
  • FIGURE Germany Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Infectious Disease Therapeutics Market share analysis by country, 2022
  • FIGURE India Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Infectious Disease Therapeutics Market share analysis by country, 2022
  • FIGURE Brazil Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Infectious Disease Therapeutics Market share analysis by country, 2022
  • FIGURE Saudi Arabia Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV2061

REPORT HIGHLIGHT

Infectious Disease Therapeutics Market size was valued at USD 68,034 Million in 2022, expanding at a CAGR of 8.2% from 2023 to 2030.

Infectious disease therapeutics encompasses the management of illnesses caused by harmful microorganisms including bacteria, viruses, fungi, and parasites. The primary objective of infectious disease therapeutics is to eradicate or regulate the proliferation and transmission of these pathogens within the body. The prompt identification and efficient treatment of individuals affected by infectious diseases have been among the most significant advancements in the field of medicine in the last century. Presently, cardiovascular disease and cancer have become the leading causes of mortality in the United States. However, the absence of innovative compounds and vaccines for the treatment and prevention of infectious diseases reaching clinical proof of concept in recent decades has resulted in a global health crisis. The emergence of new and previously unknown infectious diseases poses a grave threat to human well-being and the worldwide economy, as exemplified by the ongoing SARS-CoV-2 outbreak. To counteract these risks, it is imperative to implement comprehensive containment strategies, including virus characterization, serological testing, research on therapeutic antibodies, and the development of vaccines utilizing optimized protein expression systems to combat the rapid evolution of pathogens.

Infectious Disease Therapeutics Market- Market Dynamics

Increasing number of cases suffering with infectious diseases is expected to drive the growth of market

There is an increase in the number of cases of infectious diseases, it can drive the demand for therapeutic interventions. This may be due to factors such as changes in lifestyle, antibiotic resistance, international travel, and population density. Examples of infectious diseases include the flu, measles, HIV, strep throat, COVID-19, and salmonella. While infectious diseases are widespread globally, their prevalence varies. For instance, in the United States, approximately 1 out of every 5 individuals gets infected with the influenza virus each year, whereas the number of diagnosed prion diseases is less than 300. According to the National Center for health statistics, there are approximately 3.8 million emergency department visits with infectious and parasitic diseases as the primary diagnosis. However, the continuous advancements in biotechnology and pharmaceutical research offer opportunities for the development of more effective and targeted therapeutics for infectious diseases. Additionally, economic downturns and uncertainties can have an impact on healthcare budgets and the allocation of funds toward infectious disease therapeutics.

Infectious Disease Therapeutics Market- Key Insights

  • As per the analysis shared by our research analyst, the global Infectious Disease Therapeutics market is estimated to grow annually at a CAGR of around 8.2% over the forecast period (2023-2030)
  • Based on Mode of Treatment segmentation, Drugs was predicted to show maximum market share in the year 2022
  • Based on Infectious Type segmentation, Bacterial was the leading type in 2022
  • Based on Distribution Channel segmentation, Hospital was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Infectious Disease Therapeutics Market- Segmentation Analysis:

  • The Global Infectious Disease Therapeutics Market is segmented on the basis of Mode of Treatment, Infectious Type, Distribution Channel and Region.
  • The market is divided into three categories based on Mode of Treatment: Vaccines and Drugs. The drugs segment dominates the market. Numerous global health organizations, governments, and NGOs actively contribute to promoting the availability of drugs for infectious diseases, especially in regions where these diseases present substantial public health obstacles.
  • The market is divided into two categories based on Infectious Type: Viral, Parasitic, Fungal, Bacterial and Others. The dominance of the bacterial segment largely influences the market. Bacterial infections continue to pose a major public health concern, particularly in developing regions. Efforts from global health initiatives, in conjunction with partnerships between governments, non-profit organizations, and pharmaceutical companies, strive to enhance the availability of effective treatments and alleviate the global burden of bacterial infections.
  • The market is divided into two categories based on Distribution channel: Clinic, Hospitals and Others. Hospitals Segment dominates the market. The market is predominantly controlled by the Hospitals Segment. Hospitals play a vital role in the identification and treatment of infectious diseases. They possess diagnostic facilities, laboratories, and a team of medical professionals who collaborate to determine the causative agents of infections and recommend suitable therapeutic measures.

Infectious Disease Therapeutics Market- Geographical Insights

The Infectious Disease Therapeutics Market is geographically widespread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the nations involved in the business. In terms of growth, North America is expected to dominate the market due to the increasing prevalence of antiviral drugs and the presence of numerous manufacturers in the United States. The United States serves as a hub for research and development in the healthcare and pharmaceutical sectors, with substantial investments in R&D leading to the discovery of new therapeutic agents for infectious diseases. According to U.S. Pharmaceutical Statistics, the revenue generated by the U.S. pharmaceutical industry reached USD 550 billion in 2021, while Americans spent USD 576.9 billion on medicine during the same year. It is projected that the United States will spend between USD605 billion and USD635 billion on medicine by 2025. The development of antiviral medications plays a crucial role in treating viral infections and contributes to the overall growth of the market. The prevalence of antiviral drugs reflects the ongoing efforts in research and development to combat viral infections. Europe, on the other hand, is the second-largest region for market growth, primarily due to the rising expenditure on the prevention and diagnosis of infectious diseases.

Infectious Disease Therapeutics Market- Competitive Landscape:

Every year, the pharmaceutical industry in the United States introduces a variety of new drugs that offer significant medical benefits. However, a considerable number of these drugs are costly and contribute to the increasing healthcare expenses for both the private sector and the federal government. In order to enter the market, emerging biopharmaceutical companies, often startups or medium-sized enterprises, bring forth innovative therapeutics that specifically target infectious diseases or niche areas. Conversely, large pharmaceutical companies with well-established research and development capabilities compete in the advancement and commercialization of infectious disease therapeutics. These companies possess the necessary resources to conduct extensive clinical trials and ensure global distribution.

Recent Developments:

According to data analytics and consultancy GlobalData, Pfizer, Gilead, and GSK are expected to become the leading players in the infectious diseases market by 2023. Despite a projected 64% decrease in COVID-19 sales that year, the market is anticipated to grow at a rate of 5.7% annually, reaching $150 billion in annual sales by 2029. This growth is predicted despite the global population being largely vaccinated and the World Health Organization declaring an end to the pandemic as a global health emergency.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET KEY PLAYERS

  • Pfizer Inc.
  • Novartis AG,
  • Gilead
  • GlaxoSmithKline plc
  • Janssen Pharmaceutical, Inc.
  • F. Hoffmann-La Roche Ltd.
  • BioCryst Pharmaceuticals Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim GmbH.
  • Others

GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET, BY MODE OF TREATMENT

  • Vaccines
  • Drugs

GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET, BY INFECTIOUS TYPE

  • Viral
  • Parasitic
  • Fungal
  • Bacterial
  • Others

GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL

  • Clinic
  • Hospitals
  • Others

GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Infectious Disease Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Infectious Disease Therapeutics Market Snippet by Mode of treatment
    • 2.1.2. Infectious Disease Therapeutics Market Snippet by Infectious Type
    • 2.1.3. Infectious Disease Therapeutics Market Snippet by Distribution channel
    • 2.1.4. Infectious Disease Therapeutics Market Snippet by Country
    • 2.1.5. Infectious Disease Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Infectious Disease Therapeutics Key Market Trends

  • 3.1. Infectious Disease Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Infectious Disease Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Infectious Disease Therapeutics Market Opportunities
  • 3.4. Infectious Disease Therapeutics Market Future Trends

4. Infectious Disease Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Infectious Disease Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Infectious Disease Therapeutics Market Landscape

  • 6.1. Infectious Disease Therapeutics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Infectious Disease Therapeutics Market - By Mode of treatment

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Mode of treatment, 2022 & 2030 (%)
    • 7.1.2. Vaccines
    • 7.1.3. Drugs

8. Infectious Disease Therapeutics Market - By Infectious Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Infectious Type, 2022 & 2030 (%)
    • 8.1.2. Viral
    • 8.1.3. Parasitic
    • 8.1.4. Fungal
    • 8.1.5. Bacterial
    • 8.1.6. Others

9. Infectious Disease Therapeutics Market - By Distribution channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution channel, 2022 & 2030 (%)
    • 9.1.2. Clinic
    • 9.1.3. Hospitals
    • 9.1.4. Others

10. Infectious Disease Therapeutics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Infectious Disease Therapeutics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Infectious Disease Therapeutics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Infectious Disease Therapeutics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Infectious Disease Therapeutics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Infectious Disease Therapeutics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Infectious Disease Therapeutics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. Novartis AG,
    • 11.2.3. Gilead
    • 11.2.4. GlaxoSmithKline plc
    • 11.2.5. Janssen Pharmaceutical, Inc.
    • 11.2.6. F. Hoffmann-La Roche Ltd.
    • 11.2.7. BioCryst Pharmaceuticals Inc.
    • 11.2.8. Merck & Co., Inc.
    • 11.2.9. Boehringer Ingelheim GmbH.
    • 11.2.10. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us